Physician profile
Todd A Smith
NPI 1780649889
$1,014.90
in general payments reported to CMS, 2019-2025
19 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $194 · 2021: $79.45 · 2022: $113 · 2023: $86.78 · 2024: $30.98 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.62 | 2019-2023 | Jardiance, Tradjenta |
| Averitas Pharma INC. | $132.36 | 2024-2025 | Qutenza |
| Abbvie INC. | $112.57 | 2019-2023 | Ubrelvy |
| Amgen INC. | $97.47 | 2019-2020 | |
| Allergan, INC. | $86.86 | 2019-2020 | |
| Novo Nordisk INC | $76.46 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $67.57 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $49.83 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $27.12 | 2022-2023 | Seglentis, Livalo |
| Pfizer INC. | $26.28 | 2019-2020 | |
| Amarin Pharma, INC. | $20.94 | 2019 | |
| Abbott Laboratories | $19.85 | 2019 | |
| Glaxosmithkline, LLC. | $19.65 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.44 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.38 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $16.37 | 2019 | |
| Lilly USA, LLC | $13.98 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $11.84 | 2019 | |
| Supernus Pharmaceuticals, INC. | $11.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.